The aim of this study is to examine the association between symptoms of depression and anxiety and hypertension status. Participants (n ¼ 455, 238 women) were drawn from the Dutch Famine Birth Cohort Study. In 2002-2004, they attended a clinic assessment during which socio-demographics, anthropometrics, resting systolic blood pressure (SBP) and health behaviours were measured. Symptoms of depression and anxiety were measured using the Hospital Anxiety and Depression Scale. In 2008-2009, participants completed a questionnaire, which asked whether they ever had a physician diagnosing them as suffering from hypertension. In separate regression models that initially adjusted for age and then additionally for sex, socio-economic status, smoking, sports participation, alcohol consumption, resting SBP, antidepressive and anxiolytic medication, whether or not participants were exposed to the Dutch famine in utero, BMI and waist:hip ratio, both depression and anxiety were positively associated with hypertension status. Those who met the criterion for possible clinical depression and anxiety were also more likely to be hypertensive, and these associations remained statistically significant in the fully adjusted regression model. In conclusion, symptoms of depression and anxiety were associated with a diagnosis of hypertension assessed 5 years later, although the mechanisms underlying these associations remain to be determined.
INTRODUCTION
A number of recent studies testify to positive cross-sectional and/ or prospective associations between major depressive disorder and hypertension [1] [2] [3] and between generalised anxiety disorder and hypertension. 1 In these studies, depression and anxiety were based on a diagnostic interview. However, evidence of an association between questionnaire assessed symptoms of depression and anxiety and hypertension comes from older studies and is not wholly consistent. [4] [5] [6] [7] [8] [9] The National Health and Nutrition Examination Survey 4 and the Framingham study 5 observed that high levels of symptoms of depression and anxiety were associated with an increased risk of developing hypertension, whereas the Coronary Artery Risk Development in Young Adults study 6 found no consistent relationship between symptoms of depression and anxiety and hypertension. Other studies have demonstrated associations between depression and anxiety symptomatology and lower blood pressure. [7] [8] [9] Accordingly, we judged it timely to re-visit this issue and data collected as part of the Dutch Famine Birth Cohort Study 10 permitted re-examination of the association between symptoms of depression and anxiety and hypertension status. We hypothesised, on the balance of the previous evidence, that elevated depression and anxiety symptom levels would be associated with an increased risk for hypertension.
METHODS

Participants
Participants were selected from the Dutch Famine Birth Cohort, which comprises men and women who were born in Amsterdam, The Netherlands, between November 1943 and February 1947. The selection procedures and subsequent loss to follow-up have been described in detail elsewhere. [11] [12] [13] In 2002-2004, 740 members of the cohort provided data at a clinic assessment, performed by a trained research nurse. In 2008-2009, 455 of those who had attended the clinic returned a completed questionnaire package, which among other things, asked about diagnosed illness. The study was approved by the local Medical Ethics Committee, carried out in accordance with the Declaration of Helsinki, and with the adequate understanding and written consent of the participants.
Measures
In 2002-2004, socio-demographics, life style and anthropometrics were assessed. Socio-economic status was measured using the ISEI (International Socio-economic Index) À 92, which is based on the participant's or their partner's occupation, whichever has the higher status.
14 Measured values in the ISEI À 92 scale ranged from 16 (low status, for example a cleaning person) to 87 (high status, for example a lawyer). Participants were asked whether they were current smokers, ex-smokers or had never smoked. They were also asked whether they participated in sports and how many alcoholic drinks of different types they consumed per week, and 1 an overall units per week measure was derived. Participants had to indicate whether they were taking antidepressant and/or anxiolytic medication (NSRIs). Height was measured twice using a fixed or portable stadiometer and weight twice using Seca and portable Tefal scales. Body mass index (BMI) was computed in kg m À 2 from the averages of the two height and weight measurements. Waist and hip circumference was measured in duplicate with a flexible tape measure and an average was taken. Waist was measured midway between the costal margin and the iliac crest and hip at the widest point over the buttocks to compute the waist:hip ratio. Systolic blood pressure (SBP) was measured twice in a row on two occasions (morning and afternoon) using an automated device (Omron 705 CP/IT; Omron Healthcare UK, West Sussex, UK) and appropriate cuff sizes. Mean SBP was calculated using all available measurements.
Symptoms of depression and anxiety were measured using the Hospital Anxiety and Depression Scale (HADS). 15 The HADS is a well-recognised assessment instrument that comprises 14 items, 7 measuring depression and 7 measuring anxiety. The depression subscale emphasises anhedonia and excludes somatic items. Items are scored on a 4-point scale, 0-3; the higher the score, the greater the depression and anxiety. The HADS has good concurrent validity, 16, 17 performs well as a psychiatric screening device 17, 18 and has been shown to have acceptable psychometric properties; for example, a Cronbach's a of 0.90 for the depression items and 0.93 for the anxiety items has been reported 19 and test-retest reliability coefficients as high as 0.85 for depression and 0.84 for anxiety have been found. 17 Possible caseness for both depression and anxiety is defined by scoresX8.
The 2008-2009 questionnaire asked participants whether or not they had ever received a diagnosis of hypertension from a physician. The mean (s.d.) temporal lag between this assessment and the measurement of depression and anxiety was 5.5 (0.6) years.
Statistical analyses
Preliminary analyses of differences between participants with and without a diagnosis of hypertension were conducted using w 2 and t-tests. The main analysis was by logistic regression, where depression and anxiety served as the independent variables in separate models with hypertension status as the dependent variable. The initial models adjusted only for age at clinic assessment, whereas subsequent models additionally adjusted for sex, socio-economic status, smoking, sports participation, alcohol consumption, SBP, antidepressive and anxiolytic medication, whether or not participants were exposed to the Dutch famine in utero, BMI and waist:hip ratio. These covariates were chosen because they have been implicated in depression, anxiety and/or hypertension. Depression and anxiety were first tested as continuous variables, that is actual HADS scores, and subsequently as categorical variables, that is HADS caseness.
RESULTS
The summary characteristics of the cohort by hypertension status are presented in Table 1 . A total of 219 (48%) of the participants reported a diagnosis of hypertension at the second timepoint of assessment. HADS depression and anxiety scores were highly correlated, r (433) ¼ 0.68, Po0.001, as was HADS depression and anxiety caseness, C (coefficient of contingency) (433) ¼ 0.43, Po0.001. In regression models adjusting only for age, both depression, OR ¼ 1.13, 95% CI 1.05-1.21, P ¼ 0.001, and anxiety scores, OR ¼ 1.11, 95% CI 1.05-1.18, P ¼ 0.001, were associated with future hypertension status; the greater the symptoms of depression and anxiety the greater the likelihood that the particular person would have been diagnosed with hypertension 5 years later. These associations remained statistically significant in the fully adjusted models: for symptoms of depression, OR ¼ 1.19, 95% CI 1.09-1.30, Po0.001, and for symptoms of anxiety, OR ¼ 1.14, 95% CI 1.06-1.23, P ¼ 0.001. In these models, hypertension was also associated with a higher BMI and a higher resting SBP at the clinic assessment, P ¼ 0.001 in both cases. Men were also more likely to be hypertensive in the depression model, P ¼ 0.05.
These analyses were repeated using cutoff scores of X8 to identify possible clinical depression and anxiety. In the age-adjusted models, both depression caseness, OR ¼ 2.34, 95% CI 1.14-4.79, P ¼ 0.02, and anxiety caseness, OR ¼ 1.73, 95% CI 1.08-2.77, P ¼ 0.02, were positively associated with hypertension status. With full adjustment, the association between depression caseness and hypertension remained significant, OR ¼ 3.44, 95% CI 1.44-8.23, P ¼ 0.005, as did the association between anxiety caseness and hypertension, OR ¼ 2.08, 95% CI 1.17-3.72, P ¼ 0.01.
Sensitivity analyses
During the clinic assessment, 108 participants admitted to taking antihypertensive medication. Accordingly, it could be argued that the present prospective associations between symptoms of depression and anxiety, on the one hand, and hypertension, on the other, were largely reflecting cross-sectional associations. As a consequence we first repeated the analyses for the continuous depression and anxiety scores removing those individuals from the analyses. In the fully adjusted models, both symptoms of depression, OR ¼ 1.18, 95% CI 1.06-1.31, P ¼ 0.003, and anxiety, OR ¼ 1.14, 95% CI 1.03-1.25, P ¼ 0.008, continued to predict hypertensive status 5 years later. We also repeated the analyses of the whole sample with hypertensive medication status added as a further covariate to the fully adjusted models. Although the associations were slightly attenuated, symptoms of depression, OR ¼ 1.16, 95% CI 1.06-1.28, P ¼ 0.002, and symptoms of anxiety, OR ¼ 1.11, 95% CI 1.02-1.21, P ¼ 0.01, continued to predict future hypertension.
DISCUSSION
Almost half the current sample reported that a physician had diagnosed them as hypertensive. This is a higher prevalence than that reported in other studies, 1,3 but could reflect the age of the sample who were all over 60 years at the time of the questionnaire assessment of hypertension status as well as the close medical attention paid to this cohort. It certainly suggests, though, that there was little undiagnosed hypertension, a concern when relying on self-reports of physician diagnosis. 1 As hypothesised, participants with high levels of depression and anxiety symptoms were more likely to be hypertensive when questioned 5 years later. Hypertensive participants were also more likely to meet the criterion for possible clinical caseness for depression and anxiety at the earlier assessment. Overall, our results are in line with those from other studies comparing hypertension in those varying in symptoms of depression and anxiety 4, 5 and those with and without major depressive disorder [1] [2] [3] and with and without generalised anxiety disorder. 1 There are several possible pathways through which depression and anxiety might contribute to the development of hypertension. 20 The two most cited are unhealthy behaviours and physiological dysregulation. However, in the present analyses, the associations between symptoms of depression and anxiety and hypertension were still evident after adjustment for three of the more prominent unhealthy behaviours, smoking, non participation in sports and high levels of alcohol consumption. With regard to physiological dysregulation, altered activity of the hypothalamic-pituitary-adrenal axis has been observed in approximately 50% of depressed patients, 21 and this, in turn, may increase the risk of hypertension. Cortisol was measured in the present study during the clinical assessment, but the addition of basal cortisol to our regression models left the outcomes unaltered. Altered autonomic function has also been suggested as a possible psychophysiological mechanism. 22 However, in a previous study in the same cohort we found that those with symptoms of depression and anxiety had decreased and not increased cardiovascular stress responses. 23 In the present study, the addition of SBP and HR reactivity to our regression models left the outcomes unaltered (Po0.001 and P ¼ 0.001 for depression and anxiety, respectively). One other possibility is reverse causation, such that increased symptoms of depression and anxiety are reactions to a diagnosis of hypertension, a chronic and ultimately life-threatening condition. However, when we excluded participants who reported taking antihypertensive medication at the time of the assessment of depression and anxiety, symptoms of depression and anxiety continued to predict hypertension status at the subsequent assessment, making reverse causation an unlikely explanation.
The present study is not without limitations. First, from observational data it is impossible to determine causality and the direction of causality. However, as indicated above, reverse causation would seem to be an unlikely explanation. Nevertheless, the issue of confounding is ever present in observational studies. 24 However, we did adjust statistically for a broad range of potential confounders, including whether or not participants were exposed to the Dutch famine and SBP during the clinic assessment, and, in sensitivity analyses, whether or not participants reported taking antihypertensive medication at the earlier assessment. That the links between depression and anxiety and future hypertension survived such adjustments suggest that these associations were not simply an artefact of cross-sectional relationships. Second, we relied on a questionnaire measure of symptoms rather than formal diagnoses of major depressive and anxiety disorders. Further, use of the HADS may have lead to an underestimation of the association between depression and hypertension as it excludes somatic-affective symptoms of depression and anxiety and these may particularly increase the risk for hypertension. However, our findings are very much in accord with those from studies that did examine hypertension in the context of psychiatric diagnoses. [1] [2] [3] Third, the relative seniority of our participants and the consequently high prevalence of diagnosed hypertension could be regarded as limiting the generalisability of our findings. However, given that similar associations have emerged in middleaged cohorts, [1] [2] [3] it would appear that the relationship between depression and anxiety and hypertension transcends the age of the sample studied. Fourth, this study relied on self-report of a physician diagnosis of hypertension. However, the high prevalence of hypertension suggests that there were unlikely to be many false negatives. Further, other studies in the field have also used self-report of hypertension. 2, 3 Finally, although the high prevalence of hypertension makes it unlikely, it cannot be ruled out that depressed and anxious subjects were more likely to be diagnosed with hypertension and non-depressed/anxious subjects remained undiagnosed, as hypertension is frequently asymptomatic and depressed/ anxious subjects may have been checked more often. Another possibility would be that there were more false positives among depressed/anxious subjects due to panic-attack-related high blood pressure being misinterpreted as hypertension.
In conclusion, the present analyses indicated that symptoms of depression and anxiety were associated with a diagnosis of hypertension assessed 5 years later. These associations would not seem to be accounted for by unhealthy behaviour, nor would they appear a function of reverse causation, where increased symptoms of depression and anxiety are reactions to a diagnosis of hypertension. Further studies are needed to unravel the mechanisms underlying what appear to be fairly robust associations between psychological status and hypertension. Depression, anxiety and hypertension AT Ginty et al
